Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Media ▼Online-CME News ▼Meeting Reports Slides ▼About

Regional Symposium: Diabetes, Cardiology & Novel Therapeutic Approaches

Lectures held during regional symposium in Abu Dhabi on March 1, 2019

Recent

Lecture: Understanding the mechanism of CV benefit: How can we explain the results of GLP-1 outcome trials

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Screening for dysglycaema - when is it meaningful and how should it be performed?

Lecture - Mar. 1, 2019 - Abu Dhabi, AE - Lars Ryden, MD -Stockholm, Sweden

Lecture: Managing glucose in patients with diabetes and CVD: What did the clinical trials tell us so far?

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Cardiovascular Risk: The emerging challenge of patients with diabetes in the UAE

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Hani Sabbour, MD - Abu Dhabi , UAE

Lecture: Understanding the mechanism of CV benefit: How can we explain the results of GLP-1 outcome trials

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Screening for dysglycaema - when is it meaningful and how should it be performed?

Lecture - Mar. 1, 2019 - Abu Dhabi, AE - Lars Ryden, MD -Stockholm, Sweden

Lecture: Managing glucose in patients with diabetes and CVD: What did the clinical trials tell us so far?

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Cardiovascular Risk: The emerging challenge of patients with diabetes in the UAE

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Hani Sabbour, MD - Abu Dhabi , UAE

Lecture: Diabetes in clinical cardiology: How outcomes of new trials will impact practice

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Lars Ryden, MD Stockholm, Sweden

Lecture: Understanding the mechanism of CV benefit: How can we explain the results of GLP-1 outcome trials

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture held at regional meeting in Abu Dhabi. Member log on required

Lecture: Screening for dysglycaema - when is it meaningful and how should it be performed?

Lecture - Mar. 1, 2019 - Abu Dhabi, AE - Lars Ryden, MD -Stockholm, Sweden

Lecture held at regional meeting in Abu Dhabi. Member log on required

Lecture: Managing glucose in patients with diabetes and CVD: What did the clinical trials tell us so far?

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture held at regional meeting in Abu Dhabi. Member log on required

Lecture: Cardiovascular Risk: The emerging challenge of patients with diabetes in the UAE

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Hani Sabbour, MD - Abu Dhabi , UAE

Lecture held at regional meeting in Abu Dhabi. member log on required

Lecture: Diabetes in clinical cardiology: How outcomes of new trials will impact practice

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Lars Ryden, MD Stockholm, Sweden

Lecture held at regional meeting in Abu Dhabi. Member log on required

Regional Symposium: Diabetes, Cardiology & Novel Therapeutic Approaches

Lectures

Lecture: Understanding the mechanism of CV benefit: How can we explain the results of GLP-1 outcome trials

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Screening for dysglycaema - when is it meaningful and how should it be performed?

Lecture - Mar. 1, 2019 - Abu Dhabi, AE - Lars Ryden, MD -Stockholm, Sweden

Lecture: Managing glucose in patients with diabetes and CVD: What did the clinical trials tell us so far?

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Stephan Jacob, MD - Tubingen, Germany

Lecture: Cardiovascular Risk: The emerging challenge of patients with diabetes in the UAE

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Hani Sabbour, MD - Abu Dhabi , UAE

Lecture: Diabetes in clinical cardiology: How outcomes of new trials will impact practice

Lecture - Mar. 1, 2019 - Abu Dhabi, UAE - Lars Ryden, MD Stockholm, Sweden